rs76224631

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_172364.5(CACNA2D4):​c.2065A>G​(p.Ile689Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,613,976 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 69 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 42 hom. )

Consequence

CACNA2D4
NM_172364.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -0.615

Publications

5 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025875866).
BP6
Variant 12-1856099-T-C is Benign according to our data. Variant chr12-1856099-T-C is described in ClinVar as Benign. ClinVar VariationId is 100606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0144 (2197/152350) while in subpopulation AFR AF = 0.0479 (1990/41586). AF 95% confidence interval is 0.0461. There are 69 homozygotes in GnomAd4. There are 1056 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 69 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.2065A>G p.Ile689Val missense_variant Exon 22 of 38 ENST00000382722.10 NP_758952.4 Q7Z3S7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000382722.10 linkc.2065A>G p.Ile689Val missense_variant Exon 22 of 38 1 NM_172364.5 ENSP00000372169.4 Q7Z3S7-1
CACNA2D4ENST00000586184.5 linkc.2065A>G p.Ile689Val missense_variant Exon 22 of 37 5 ENSP00000465060.1 Q7Z3S7-5
CACNA2D4ENST00000587995.5 linkc.1990A>G p.Ile664Val missense_variant Exon 21 of 37 5 ENSP00000465372.1 K7EJY1
CACNA2D4ENST00000585708.5 linkc.1873A>G p.Ile625Val missense_variant Exon 22 of 37 5 ENSP00000467697.1 Q7Z3S7-6
CACNA2D4ENST00000588077.5 linkc.1873A>G p.Ile625Val missense_variant Exon 22 of 38 5 ENSP00000468530.1 Q7Z3S7-4
CACNA2D4ENST00000444595.6 linkn.*311A>G non_coding_transcript_exon_variant Exon 22 of 37 1 ENSP00000403371.2 E7EUE0
CACNA2D4ENST00000444595.6 linkn.*311A>G 3_prime_UTR_variant Exon 22 of 37 1 ENSP00000403371.2 E7EUE0

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2193
AN:
152232
Hom.:
69
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0479
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00910
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00379
AC:
944
AN:
249262
AF XY:
0.00298
show subpopulations
Gnomad AFR exome
AF:
0.0453
Gnomad AMR exome
AF:
0.00440
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000655
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
AF:
0.00177
AC:
2593
AN:
1461626
Hom.:
42
Cov.:
32
AF XY:
0.00162
AC XY:
1180
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.0454
AC:
1519
AN:
33472
American (AMR)
AF:
0.00445
AC:
199
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53400
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.000495
AC:
550
AN:
1111816
Other (OTH)
AF:
0.00459
AC:
277
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
144
288
431
575
719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2197
AN:
152350
Hom.:
69
Cov.:
33
AF XY:
0.0142
AC XY:
1056
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.0479
AC:
1990
AN:
41586
American (AMR)
AF:
0.00908
AC:
139
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68036
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
100
199
299
398
498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00788
Hom.:
12
Bravo
AF:
0.0158
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0377
AC:
152
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.00434
AC:
525
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.000830

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal cone dystrophy 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.016
DANN
Benign
0.90
DEOGEN2
Benign
0.021
T;.;.;.;.;.
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.064
N
MetaRNN
Benign
0.0026
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;.;.;L;.;.
PhyloP100
-0.61
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.26
N;.;.;.;.;.
REVEL
Benign
0.020
Sift
Benign
0.78
T;.;.;.;.;.
Sift4G
Benign
0.82
T;T;T;T;T;T
Polyphen
0.0010
B;.;.;.;.;.
Vest4
0.16
MVP
0.12
MPC
0.11
ClinPred
0.0033
T
GERP RS
-1.2
Varity_R
0.023
gMVP
0.43
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76224631; hg19: chr12-1965265; COSMIC: COSV99028010; COSMIC: COSV99028010; API